We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




GI Bleeding Raises Colorectal Cancer Risk in Anticoagulated Patients

By HospiMedica International staff writers
Posted on 24 Feb 2020
A new study reveals that in anticoagulated atrial fibrillation (AF) patients, gastrointestinal (GI) bleeding confers a high absolute risk of incident colorectal cancer (CC). More...


Researchers at Gentofte University Hospital (Hellerup, Denmark), Aalborg University Hospital (Denmark), the University of Copenhagen (KU; Denmark), and other institutions conducted a study involving 125,418 AF patients who began oral anticoagulant (OAC) therapy in order to investigate to what extent lower GI tract bleeding represents the unmasking of an occult CC. In all, 2,576 patients with GI bleeding were identified, of whom 140 were diagnosed with CC.

The results revealed that in all age groups, high risks of CC after lower GI tract bleeding were observed, with the absolute one-year risk ranging from 3.7% in the age groups younger than 65, and up to 8.1% in the 76 to 80 years of age group. Overall, OAC patients with lower GI tract bleeding had a 10-15 fold increased one year risk for a diagnosis of CC if they were older than 65, and 24 times that risk if they were 65 or younger, compared with those without GI bleeding on OAC. The study was published on February 7, 2020, in the European Heart Journal.

“Patients should be informed when initiating treatment with anticoagulants that blood in the stool should not be dismissed as a benign consequence of OAC therapy, but always examined for a potential underlying malignant cause,” said lead author Peter Vibe Rasmussen, MD, of Gentofte University Hospital and KU. “We think our data support that all eligible patients presenting with a sign or symptom of lower GI bleeding should be offered examinations to rule out cancer.”

Patients with AF are routinely treated with OACs as the primary therapeutic strategy for preventing stroke. Bleeding complications following OAC treatment are relatively frequent, and GI tract bleeding is considered a well-known marker of malignant lesions in the lower GI tract. OAC therapy has previously been hypothesized as a ‘stress-test’, which could potentially unveil an occult colorectal CC.

Related Links:
Gentofte University Hospital
Aalborg University Hospital
University of Copenhagen



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Rapid Sepsis Test
SeptiCyte RAPID
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.